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Abstract
Background: Rapid restoration of vessel patency after acute myocardial infarction is
key to reducing myocardial muscle death and increases survival rates. Standard
therapies include thrombolysis and direct PTCA. Alternative or adjunctive emergency
therapies that could be initiated by minimally trained personnel in the field are of
potential clinical benefit. This paper evaluates a method of accelerating reperfusion
through application of low frequencymechanical stimulus to the blood carrying vessels.
Materials andmethod: We consider a stenosed, heparinized flow system with
aortic-like pressure variations subject to direct vessel vibration at the occlusion site or
vessel deformation proximal and distal to the occlusion site, versus a reference system
lacking any form of mechanical stimulus on the vessels.
Results: The experimental results show limited effectiveness of the direct mechanical
vibration method and a drastic increase in the patency rate when vessel deformation is
induced. For vessel deformation at occlusion site 95% of clots perfused within 11
minutes of application of mechanical stimulus, for vessel deformation 60 centimeters
from the occlusion site 95% percent of clots perfused within 16 minutes of stimulus
application, while only 2.3% of clots perfused within 20minutes in the reference system.
Conclusion: The presented in-vitro results suggest that low frequency mechanical
actuation applied during the pre-hospitalization phase in patients with acute
myocardial infarction have potential of being a simple and efficient adjunct therapy.
Introduction
Myocardial infarction and stroke (arterial thrombosis) comprise the leading causes of
death and disability in the developed world [1]. Emergency percutaneous coronary inter-
vention is the preferred treatmentmethod for acutemyocardial infarction, but emergency
iv thrombolysis still plays an important role [2,3]. This is especially true in remote areas,
where the geographic distance to hospitals with a cardiac catheterization laboratory elim-
inates the possibility of fast treatment. As the delay in blood flow restoration at the
occlusion site is the main factor of clinical outcome [4], rapid treatment after the onset
of symptoms is crucial. Late presentation to an angioplasty facility and frequent incom-
plete reperfusion following iv thrombolysis have stimulated research for alternative or
adjunctive emergency therapies that could be initiated prior to patient arrival to hos-
pital. Ultrasound assisted thrombolysis using catheter mounted transducers has been
investigated and there is evidence that it accelerates the rate of thrombolysis [5,6] and
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increases the penetration of lytic enzymes into the thrombus [7,8]. Based on these results,
non-invasive transcutaneous application of ultrasound was investigated. Initial clinical
evaluation in patients with acute myocardial infarction confirm the safety of application
when pulsed ultrasound was used to avoid excessive tissue heating [9]. Nevertheless, sub-
sequent clinical trials of thrombolysis assisted by externally applied ultrasound failed to
prove significant improvement in reperfusion rates [10]. Furthermore, accurate place-
ment of the ultrasound transducer was deemed crucial to treatment efficacy eliminating
the possibility of application by untrained personnel [10]. Finally, it has been discussed
that lower frequency ultrasound, offering better tissue penetration, provides better results
[6,8]. An intragastral resonator delivering low frequency mechanical waves has been
reported to disrupt big blood clots, tablets, food, or scybala and was proposed as a possi-
bility during endoscopic examinations [11]. Furthermore, Folts [12] reported clearing of
thrombosed arteries in an open animal model when external tapping was applied directly
to the occlusion site. Lower frequency mechanical vibration offers better tissue penetra-
tion and can be applied to the external chest wall of the patient, and therefore has been
proposed as a safe and effective substitute to ultrasound [13-16]. We hypothesize that
such a mechanical approach could be a safe and effective adjunct method to clot disrup-
tive drug therapy, thereby accelerating reperfusion of thrombolytically occluded vessels.
External mechanical actuation can be started in the field by minimally trained emer-
gency personnel or even by bystanders immediately after the onset of symptoms. It has
been hypothesized that application of mechanical stimulus can increase mixing of throm-
bolytic drugs in patients bloodstream, thus improving drug penetration to the occlusion
site. Therefore, lower doses of thrombolytic drugs could be used during pharmacological
therapy, which might result in a lower risk of bleeding. This could be of clinical relevance,
specifically for patients with a relative contraindication for thrombolytic drug use [13,14].
Yohannes and Hoffmann [14] studied the impact of mechanical vibrations applied
through an attenuating barrier on re-canalization of a thrombosed flow system. They con-
cluded that localized transcutaneous low frequencymechanical vibrationmight serve as a
safe and practical method to accelerate clot dissolution. Their study had some limitations,
including:
• The model for stenosis site was vessel deformation, rather than a narrowing, so the
actual lumen area remained unchanged.
• The pressure was gravitationally applied instead of creating a pressurized flow system
and the actual frequency and amplitude of the mechanical actuation induced was
assumed, not measured.
• The vibratory stimulus was applied directly over the occlusion, the effect of improper
device placement was not investigated.
Previous studies have established the beneficial effect of mechanical actuation on accel-
erating reperfusion. However, the exact mechanism of actuation of the thrombosed vessel
resulting from transcutaneous application of mechanical vibrations has not been explored
in detail. Externally applied vibration can both induce vibration of the blood carrying ves-
sels and their deformation. Even though it has been stated that low frequency vibration
penetrates tissue better than ultrasound alleviating the importance of device placement
precisely over the occlusion, no research to date has explored the efficacy of stimulus
application remotely from the clot.
Marzencki et al. BioMedical Engineering OnLine 2013, 12:121 Page 3 of 17
http://www.biomedical-engineering-online.com/content/12/1/121
The goal of this study is to verify the effectiveness of various methods of low fre-
quency mechanical actuation in accelerating in-vitro reperfusion. To this end, we studied
a stenosed, partly occluded heparinized flow system subject to arterial-like pressure vari-
ations with one of three actuation methods applied: direct vibration of the occlusion
site, deformation of vessel 20 mm proximal to the occlusion sites and deformation of a
larger vessel 60 cm distal to the occlusion sites. We hypothesize that vibration of vessels
promotes mixing and penetration of anti-thrombolytic agents in the bloodstream which
could lead to accelerated reperfusion. Vessel deformation on the other hand, induces local
pressure variations that result in both increased mixing of drugs in blood and mechanical
deformation of the blood clot and thus its accelerated disintegration. These hypotheses
are herein investigated.
Materials andmethod
The experiments described in this paper were performed at the University of British
Columbia Farm, 6182 South Campus Road, Vancouver, BC, Canada, in accordance with
ethics approval 2009s0630.
Flow system
A schematic of the setup prepared for this experiment is shown in Figure 1 and a photo-
graph is presented in Figure 2. It is intended to model a stenosed arterial system subject
to systemic pressures. It consists of a heparinized flow system and one of three actuation
setups. A rolling peristaltic pump (Manostat 72-300-000) induces flow of a buffer fluid
(heparinized saline solution) through a tubing system and through eight narrowingsmod-
eling the stenosis sites. The fluid was aggregated in a constant temperature bath (Vanlab,
VWR Scientific, Inc) and kept at 37°C. For all experiments, a reference setup identical to
the test setup but absent the actuation elements was used to provide a baseline result. The
two setups (i.e. the reference and the actuated one) shared the buffer fluid in the beaker.
Tubing types used to build the flow system were chosen to be similar in size and mechan-
ical properties to human arteries [17]. Types, dimensions, and properties of the tubing
chosen for each element of the system are reported in Table 1. A bypass was installed
Figure 1 The flow system. Schematic representation of the experimental setup used in this study with A, B,
and C indicating the location of the corresponding actuation sites.
Marzencki et al. BioMedical Engineering OnLine 2013, 12:121 Page 4 of 17
http://www.biomedical-engineering-online.com/content/12/1/121
Figure 2 Experimental setup, photograph of the experimental setup used in this work.
to provide a path around the occlusion sites to simulate more closely an actual obstruc-
tion in a living organism, where not all vessels are blocked simultaneously. The lumen
of the bypass was adjustable to control the flow rate and the induced pressure. The total
capacity of the tubing was between 165 ml and 200 ml depending on the actuation system
used. The fluid pressure was measured at the edge of one of the narrowings, as shown in
Figure 1, using a pressure sensor (MPXM2053GS, Freescale Semiconductor, Inc, Austin,
TX) connected to an instrumentation amplifier (INA110, Texas Instruments, Dallas, TX).
A bi-axial MEMS accelerometer (ADXL278, Analog Devices, Inc., Norwood, MA) was
used to measure motion induced at the actuation site.
Data acquisition was done in the LabView environment using a custom made Virtual
Instrument and a data acquisition module (NI USB-6009 DAQ, National Instruments,
Austin, TX). Continuous data acquisition was performed throughout the experiment at
a sampling rate of 1 kHz and the acquired data was stored in a text file on a personal
computer.
During the experiment, flow in the systemwas regulated using the adjustable narrowing
on the bypass to 2 ml/s and pressure varying between 25 kPa and 30 kPa (188 mmHg and
225 mmHg respectively).
Stenosis sites
There was a total of 16 narrowings in the experimental setup used to model steno-
sis sites, eight for the reference side and eight for the actuated side. Each narrowing
in a given setup was identical and created by inserting a 15 mm plastic tube element
Table 1Materials used to construct the flow system and the clot formation setup
Vessel Material Length ID [mm] OD [mm] Durometer P/N Brand
Connectors Silicone 2m 4.76 7.95 50A SMD-188A-25 X-Med
Clot formation Silicone 30 cm 4.76 7.95 50A SMD-188A-25 X-Med
Narrowing outside PVC 120 mm 4.76 6.35 66A TMT-187A-50 Tygon
Narrowing inside PVC 15 mm 1.59 4.76 66A TMT-062B-10 Tygon
Large tube PVC 120 mm 9.5 12.7 55A 8000-0120 T. Scientific
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(narrowing inside in Table 1) into a larger plastic tube (narrowing outside in Table 1),
as depicted in Figure 3. In order to insert the smaller tube, the larger tube was cut
in half and then glued around the smaller tube with cyanoacrylate glue (Loctite Pro
Liquid) and sealed with a silicon glue-sealant (Dow Corning 732). Finally, the tube was
cut into proper length and desired proportions before and after the narrowing with a total
length of 120 mm. The resulting structure presented a 90% luminal stenosis. Installation
of narrowings in the actuated and the reference systems was randomized. The internal
diameter and length of the tubing was chosen to correspond to the internal diameter
of the human coronary artery, based on the middle section of the right coronary artery
[18].
Buffer fluid
The buffer fluid used in the systemwas a solution of 2000Units of heparin (H3393, Sigma-
Aldrich, Saint Louis, MI) in 1000 ml of 0.9% Sodium Chloride IV injection USP solution
(Baxter International, Deerfield, IL). The fluid was brought to 37°C prior to the experi-
ment and kept at a constant temperature. We used very low concentrations of 2 USP units
of heparin per ml, much below the amount of heparin needed to prevent coagulation in
whole blood which is 20 to 50 units per mL of whole blood [19].
Actuation
This work investigates the effect of various types of low frequency mechanical actuation
on accelerating vessel reperfusion. In each experiment, one of the three actuation setups
described below and depicted in Figures 4, 5 and 6 was used and positioned as depicted
in Figure 1. The resulting pressure at the narrowings with no actuation, pressure during
actuation and the acceleration at the application site are shown in Figures 7, 8 and 9 for
each of the three corresponding setups from Figures 4, 5 and 6.
A: The stenosis sites were directly vibrated at 5 g amplitude (2 mm displacement at 24
Hz). Themechanical stimulus was applied at the occlusion site and the lumen of the vessel
was not directly deformed.
B: Deformation was applied to the occluded vessel 20 mm before each stenosis site. In
this case, the vessel was directly deformed and the clot was placed between the narrowing
and the application site, but was not directly deformed. The vessel was reaching 80% focal
occlusion at the deformation site during actuation.
C: Deformation was applied to a vessel with an inside diameter larger than the one of the
stenosed vessels, corresponding to the diameter of human aorta in the abdominal region
[17]. The actuation site was placed 60 centimeters from the stenosis site. In this case, no
Figure 3 Construction of the narrowing. Stenosis site construction, where d1 = 4.76mm, d2 = 1.59mm
and l1 = 15mm.
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Figure 4 In-vitro setup A. Actuation setup A where the stenosis sites are directly vibrated.
Figure 5 In-vitro setup B. Actuation setup B where mechanical deformation is applied to the vessel
proximal to the stenosis site.
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Figure 6 In-vitro setup C. Actuation setup C where mechanical deformation is applied 60 cm from the
stenosis site to a larger vessel.
mechanical stimuli was applied directly to the narrowings. The amplitude of deformation
applied to the large vessel was equal to 3 mm.
In all the three cases, the mechanical movement was generated by a DC motor
(Unionwell LW2920D120) with shaft extending from both ends coupled with an alu-
minum beam through a lever system implying a quasi linear motion. The motor
location could be adjusted horizontally and vertically to accommodate various con-
figurations of distances. The aluminum beam was either coupled with a free mov-
ing narrowing (setup A) or induced a direct deformation of the vessel immobilized
by a wooden spacer (setups B and C). In cases A and B, the actuation was close
to the blood clot, and in the case C remote from the clot. The induced displace-
ment was constant independent of frequency. The actuation frequency was controlled
through the DC voltage supplied to the motor and observed using an accelerome-
ter (AD22286, Analog Devices, Cambridge, MA) mounted on the aluminum beam.
For all the three experiments, the actuation frequency was between 20 Hz and
24 Hz.
Experimental procedure
A total of 198 occlusions was successfully tested in all experiments with 27 occlu-
sions subject to direct vibrations, 56 subject to local vessel deformation, 37 subject
to remote vessel deformation and the remaining 78 providing the baseline result.
A total of 28 experiments was discarded due to occlusion instability (immediate
perfusions).
Clot preparation
Whole blood was collected from the left jugular vein of a sheep (female, Ovis aries, Suf-
folk breed) elevated in a controlled environment at UBC Farm. Blood was drawn under
standardized conditions into a 60 ml syringe and immediately distributed into sterile sil-
icon tubing (ID 4.76 mm), sealed inside a double zip-lock bag and placed into a water
bath held at 37°C. Ninety minutes from blood extraction, the clotted blood was removed
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Figure 7 Pressure and acceleration, setup A. Pressure in the flow system with and without mechanical
stimulus and acceleration measured at the actuation site while using setup A.
from the bath and inspected visually for retraction. The retracted clot was pressed out of
the silicon tube and verified for uniformity. The long columnar clot was then cut into 15
mm pieces and each piece was weighted separately using a digital scale (VB-302A, Virtual
Measurements & Control, Santa Rosa, CA). The resulting distribution of clot weights in
each experiment is detailed in Figures 10, 11 and 12. Cut and weighted clots were imme-
diately inserted into the flow system by disconnecting the narrowings separately one by
one at clamping, placing a clot inside the tube with a spatula and subsequently flooding it
with the fluid from the beaker and reconnecting the narrowing. Upon re-pressurization
the clots occluded the closest stenosis site. Special care was taken to remove all air bubbles
from the system prior to pressurizing and not to damage the clots mechanically. The clot
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Figure 8 Pressure and acceleration, setup B. Pressure in the flow system with and without mechanical
stimulus and acceleration measured at the actuation site while using setup B.
distribution between the stenosed channels and the reference versus the actuated setups
was randomized.
Flow system
In order to verify occlusion stability, after insertion of all clots, the systemwas pressurized
using the peristaltic pump for 120 seconds without applying actuation. Narrowings where
clots perfused within this period were clamped and labeled as immediate perfusions.
The reference and the actuated setups were functionally identical during this period.
Throughout all the experiments, 12.23% of clots perfused prior to actuation (immediate
perfusions).
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Figure 9 Pressure and acceleration, setup C. Pressure in the flow system with and without mechanical
stimulus and acceleration measured at the actuation site while using setup C.
Actuation
After the initial test for 120 seconds, the actuation setup was activated. Perfusions were
detected through abrupt reduction of the buffer fluid pressure at the narrowings. Each
perfused narrowing was immediately clamped to maintain constant pressure in the sys-
tem. The time to perfusion was noted from the activation of actuation. After 20 minutes
from the start of actuation, the system was stopped and all the remaining clots (that did
not perfuse) were removed, drained and re-weighted.
Results
The three setups described in the previous section were evaluated for their efficiency in
accelerating reperfusion of occluded vessels.
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Figure 10 Histogram of initial clot masses for setup A. Distribution of clot masses prior to the
experiments using the setup A.
Setup A
In this case, the stenosis sites were directly vibrated. The pressure variations at the occlu-
sion sites both prior to actuation and during actuation along with acceleration during
actuation are presented in Figure 7. It can be seen that the mechanical vibrations have
minimal impact on the fluid pressure at the narrowings.
Out of 35 tests, only 1 perfusion occurred within the duration of actuation (20
minutes) after 13 minutes on the actuated side resulting in a TIMI 2 flow. Therefore, only
the change in the clot masses was evaluated. Figure 13 presents a histogram of clot mass
changes evaluated as the difference between the clot mass post experiment versus the clot
Figure 11 Histogram of initial clot masses for setup B. Distribution of clot masses prior to the
experiments using the setup B.
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Figure 12 Histogram of initial clot masses for setup C. Distribution of clot masses prior to the
experiments using the setup C.
mass prior to the experiment. The average mass change is -15.89% (σ = 26.4%) for the
reference system and -12.16% (σ = 19.1%) for the actuated system. The fact that mass
of some clots increased may be due to water absorption, or imperfect soaking method
employed.
Setup B
In this case, a direct mechanical deformation of the vessel was imposed near the steno-
sis site. Figure 8 presents the pressure variations prior to actuation and during actuation
Figure 13 Clot mass change. Clot mass change post experiment versus prior to experiment when using
setup A. Negative percentage value signifies reduction in clot mass.
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along with acceleration at the application site while using setup B to impose vessel
deformation. It can be seen that vessel deformation is inducing significant pressure vari-
ations at the occlusion site and thus at the blood clot. Contrary to the case where
direct vibrations were applied, in the deformation case over 95% of the narrowings
were successfully perfused resulting in a TIMI 3 flow within 11 minutes of the onset
of actuation while only two perfusions (5.3%) occurred on the reference side within 20
minutes.
Setup C
In this case, a direct mechanical deformation was imposed 60 centimeters from the
stenosis sites to the fluid carrying vessel with a larger ID.
Figure 9 presents the pressure variations at the narrowings with and without actuation
and the acceleration at the application site while using setup C. It can be seen that as in the
case of using setup B, there are significant pressure variations at the occlusion site induced
by the actuation. As a result of actuation induced using setup C, over 95% of narrowings
perfused within 16 minutes of application resulting in a TIMI 3 flow, whereas there was
no perfusion on the reference side. Only one occlusion out of 37 actuated narrowings did
not perfuse within 20 minutes.
Setups B and C have proven to be the most efficient in accelerating reperfusion.
Figure 14 presents distribution of times to perfusion for the actuated side for those setups.
The average time to perfusion was 3 minutes 50 seconds for setup B and 4minutes 27 sec-
onds for setup C. Figure 15 summarizes the patency rate for all the experiments. It can be
seen that setups B and C have very similar distribution of times to perfusion which indi-
cates that deformation of a large vessel distant from the occlusion site is equally efficient
as deformation of vessels very close to the occlusion site. On the other hand, patency rate
for setup A is very close to the baseline.
Figure 14 Times to perfusion. Histogram of times to perfusion while using setup B or setup C to induce
vessel deformation.
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Figure 15 Perfusion rate. Reperfusion rate among the tested setups for the first 20 minutes of actuation.
Discussion
Our study evaluates the effectiveness of various actuation methods in accelerating re-
perfusion of occluded vessels in an in-vitro model. The experimental results show that
while keeping pressure in the system at systemic levels, 95% of occlusions perfuse within
11minutes of application in the case of a mechanical deformation applied at the occlusion
site and 95% of the occlusions perfuse within 16 minutes of application if a mechanical
deformation is applied 60 centimeters from the occlusion site. Contrary to indications
from previous publications, we demonstrated that direct vibration of the occlusion sites
has no significant impact on accelerating reperfusion.
The notion that mechanical actuation positively affects the speed at which a blood
thrombus disintegrates was suggested in previous publications. However, our study is
the first to systematically evaluate the various proposed application methods. The three
approaches examined in this study apply either displacement or deformation at specific
frequencies. We theorized that vessel vibration would induce more mixing in the buffer
fluid and promote clot lysis, but our experimental results prove otherwise. No signifi-
cant improvement in reperfusion time was observed when occluded vessel was directly
vibrated. It may be due to the very narrow lumen of the vessels and the lack of pres-
sure waves that would deform the clot and stimulate mixing. On the other hand, we
demonstrated that pressure variations induced by vessel deformation drastically improve
reperfusion rate. Mechanical stimuli create pressure waves that are transferred by the
fluid to the occlusion site. If deformation is applied distant to the occlusion site, the
amplitude of pressure variations is reduced due to compliance of vessels (albeit low for
aortic walls). Still, as the blood is a non-compressible fluid, the pressure waves are usually
well transferred through the circulatory system of a living organism [20]. Fluid viscos-
ity and its traction on the vessel walls imply pressure non-uniformity in the lumen of
the vessel, as depicted schematically in Figure 16, which can have further positive impact
on clot dissolution. If the central part of the thrombus is subject to higher forces than
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Figure 16 Pressure distribution. Schematic representation of pressure distribution in a vessel induced by
vessel deformation distant from stenosis site.
the outer parts, then clot deformation is more prominent and lysis is further promoted.
Furthermore, arterial thrombus is often characterized by presence of alternating layers
called Lines of Zahn [21-23]. Lines of Zahn are characteristic of thrombus formed at
rapid arterial blood flow, like the one in the coronary arteries, where laminations are
produced by deposition of platelets and fibrin (pale layers) and red blood cells (dark lay-
ers). A blood clot presenting such a layered construction would be much more prone to
deformations induced by the nonuniform pressure distribution applied at the front of the
thrombus.
During our experiments, we observed that after perfusion the blood clot is split into
multiple long and narrow fragments that easily pass through occlusion sites when recir-
culated in the system. It can be argued that in-vivo such fragments may occlude further
arteries leading to a “no reflow” situation known from unsuccessful angioplasty proce-
dures. Nevertheless, in the presented method, the fragments of disintegrated clot are
sufficiently large not to spread across all capillaries in the myocardial muscle. Therefore,
any displacement of the occlusion site down the bloodstream would enhance delivery of
the oxygenated blood thus reducing the extent of myocardial muscle death and increasing
the chances of patient survival.
The fact that even distant vessel deformation accelerates clot lysis opens way to appli-
cation of mechanical stimuli away from the chest area of patients suffering from acute
myocardial infarct. Furthermore, as it is not critical to apply the stimulus directly over
the occlusion site, contrary to ultrasound, lack of exact knowledge of the occlusion site
location does not exclude efficient treatment, as long as a major artery is targeted. A
feedback system, where a high frequency blood pressure monitor would detect pressure
waves in an easily accessible artery (e.g. thyroid), could be used to verify the efficiency
of application. Thus, such method could be effectively applied in the field using a simple
external massager device operated by minimally trained personnel. Finally, as the chest
area is very sensitive, any prolonged mechanical deformation is undesirable, contrary to
the more robust abdominal section containing large blood carrying vessels, like the aorta.
In order to induce a displacement of 3 mm in amplitude at the aorta level, a significant
displacement has to be applied at the surface of the body. Our tests indicate that peak to
peak displacement of 8 mm at 30 Hz applied using a commercial massager (Max F-209,
Brookstone, Merrimack, NH) can be tolerated in the abdominal area for at least 20
minutes with an application force of 50 N. The in-vitro results presented in this paper
indicate that such application would be sufficient to promote reperfusion in case of acute
myocardial infarction.
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The limitations of our study mostly consisted in the level of fidelity with which the
in-vitro system represents an actual circulatory system. We studied the effect of various
methods of application without analyzing the mechanism of mechanical stimulus transfer
through tissues in a living organism. Furthermore, the presented study was limited to
the use of heparin, while application of more potent thrombolytic drugs could affect the
results. We are considering these limitations in our future experiments.
Conclusion and future work
The presented study evaluated the effectiveness of various types of low frequency
mechanical actuation in accelerating reperfusion. A simplified in-vitro model of blood-
stream during myocardial infarction was created employing a stenosed, heparinized flow
system subject to systemic levels of pressure.
We observed complete reperfusion resulting in TIMI 3 flow in 95% of cases after 11
minutes of vessel deformation at the occlusion site and after 16 minutes of vessel defor-
mation 60 centimeters from the occlusion site, while there was only 2.3% perfusions in
the reference system within 20 minutes. The presented results demonstrate that low fre-
quency deformation of blood carrying vessels can be used to accelerate reperfusion, which
is of great importance in helping patients suffering from acute myocardial infarction. A
simple device can be constructed to apply external mechanical stimulus in the abdomen
area of patient’s torso that induces deformation of a major artery, e.g. the aorta. Such
method would be non-invasive, safe, inexpensive and suitable for use by inexperienced
emergency personnel in the field.
In the future, we plan to continue in-vitro evaluation of the proposed method using
various anti-thrombolytic agents dissolved in the buffer fluid and a system that more
closely represents the human body. Upon successful verification of this technique, we will
proceed with in-vivo testing.
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